These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37777655)

  • 41. Allergic rhinitis and inflammatory airway disease: interactions within the unified airspace.
    Marple BF
    Am J Rhinol Allergy; 2010; 24(4):249-54. PubMed ID: 20819460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Allergic rhinitis in pediatrics: recommendations for diagnosis and treatment].
    Agüero CA; Sarraquigne MP; Parisi CAS; Mariño AI; López K; Menéndez Porfirio B; Sasia L; Lozano A; Bovina Martijena MDP; Gervasoni ME; Bózzola M; Colella M; Saranz R; Orellana J; Máspero JF; Seisdedos V; Behrends I; Blanco A; Dayán P; Matta Ruffolo M; Aráoz I; Casaniti C; García J; Skrie V; García M; Suárez García JM; Orellano F; Luconi N; Bandin G
    Arch Argent Pediatr; 2023 Apr; 121(2):e202202894. PubMed ID: 36924507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rupatadine improves nasal symptoms, quality of life (ESPRINT-15) and severity in a subanalysis of a cohort of Spanish allergic rhinitis patients.
    Valero A; Izquierdo I; Giralt J; Bartra J; del Cuvillo A; Mullol J
    J Investig Allergol Clin Immunol; 2011; 21(3):229-35. PubMed ID: 21548452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical efficacy of immunotherapy in allergic rhinitis.
    Oktemer T; Altıntoprak N; Muluk NB; Senturk M; Kar M; Bafaqeeh SA; Bellussi L; Passali D; Cingi C
    Am J Rhinol Allergy; 2016 Sep; 30(5):4-7. PubMed ID: 27658025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How molecular diagnosis may modify immunotherapy prescription in multi-sensitized pollen-allergic children.
    Del-Río Camacho G; Montes Arjona AM; Fernández-Cantalejo Padial J; Rodríguez Catalán J
    Allergol Immunopathol (Madr); 2018; 46(6):552-556. PubMed ID: 30017214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunotherapy in allergic rhinitis and lower airway outcomes.
    Cardona V; Luengo O; Labrador-Horrillo M
    Allergy; 2017 Jan; 72(1):35-42. PubMed ID: 27439141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent advances in allergic rhinitis.
    Hoyte FCL; Nelson HS
    F1000Res; 2018; 7():. PubMed ID: 30210782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pediatric allergic rhinitis and comorbid disorders.
    Lack G
    J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S9-15. PubMed ID: 11449201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Update on prescription and over-the-counter histamine inverse agonists in rhinitis therapy.
    DuBuske L; Kowal K
    Curr Allergy Asthma Rep; 2009 Mar; 9(2):140-8. PubMed ID: 19210904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evolving paradigm in the management of allergic rhinitis-associated ocular symptoms: role of intranasal corticosteroids.
    Blaiss MS
    Curr Med Res Opin; 2008 Mar; 24(3):821-36. PubMed ID: 18257976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Update on the medical treatment of allergic rhinitis.
    Cingi C; Kayabasoglu G; Nacar A
    Inflamm Allergy Drug Targets; 2009 Jun; 8(2):96-103. PubMed ID: 19530991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimising the management of allergic rhinitis: an Australian perspective.
    Walls RS; Heddle RJ; Tang ML; Basger BJ; Solley GO; Yeo GT
    Med J Aust; 2005 Jan; 182(1):28-33. PubMed ID: 15651945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Special considerations in treatment of allergic rhinitis in the elderly: role of intranasal corticosteroids.
    Slavin RG
    Allergy Asthma Proc; 2010; 31(3):179-84. PubMed ID: 20615319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparing available treatments for pollen-induced allergic rhinitis in children.
    Klain A; Indolfi C; Dinardo G; Decimo F; Tosca MA; Miraglia Del Giudice M; Ciprandi G
    Expert Rev Clin Immunol; 2022 Aug; 18(8):835-843. PubMed ID: 35726790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selecting the optimal oral antihistamine for patients with allergic rhinitis.
    Lehman JM; Blaiss MS
    Drugs; 2006; 66(18):2309-19. PubMed ID: 17181374
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hungarian adaptation and launch of the 2019 ARIA care pathways of allergic rhinitis in Hungary].
    Kraxner H; Hirschberg A; Nékám K
    Orv Hetil; 2020 Dec; 161(49):2059-2071. PubMed ID: 33279881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment strategy of allergic rhinitis in the face of modern world threats.
    Rapiejko P; Jurkiewicz D; Pietruszewska W; Zielnik-Jurkiewicz B; Woroń J; Lipiec A
    Otolaryngol Pol; 2018 Apr; 72(2):1-12. PubMed ID: 29748453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.
    Richards JR; Stumpf JL
    Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Childhood allergic rhinitis].
    Marmouz F
    Allerg Immunol (Paris); 2000 Dec; 32(10):381-7. PubMed ID: 11209470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.